USD 7.41
(19.71%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 259.04 Million USD | -6.55% |
2022 | 277.19 Million USD | 9.65% |
2021 | 252.78 Million USD | 3.07% |
2020 | 245.26 Million USD | 64.77% |
2019 | 148.85 Million USD | 30.63% |
2018 | 113.95 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 62.79 Million USD | 5.49% |
2024 Q3 | 61.04 Million USD | -2.78% |
2024 Q1 | 59.52 Million USD | -15.78% |
2023 Q3 | 61.92 Million USD | -0.84% |
2023 FY | 259.04 Million USD | -6.55% |
2023 Q1 | 64 Million USD | -19.22% |
2023 Q2 | 62.44 Million USD | -2.43% |
2023 Q4 | 70.67 Million USD | 14.14% |
2022 Q2 | 64.51 Million USD | 0.44% |
2022 Q1 | 64.23 Million USD | -11.71% |
2022 Q3 | 69.2 Million USD | 7.27% |
2022 Q4 | 79.23 Million USD | 14.48% |
2022 FY | 277.19 Million USD | 9.65% |
2021 Q2 | 60.21 Million USD | 4.55% |
2021 Q4 | 72.75 Million USD | 16.92% |
2021 Q3 | 62.22 Million USD | 3.33% |
2021 FY | 252.78 Million USD | 3.07% |
2021 Q1 | 57.59 Million USD | -4.69% |
2020 FY | 245.26 Million USD | 64.77% |
2020 Q4 | 60.43 Million USD | -3.39% |
2020 Q3 | 62.55 Million USD | -8.78% |
2020 Q2 | 68.56 Million USD | 27.65% |
2020 Q1 | 53.71 Million USD | 19.28% |
2019 FY | 148.85 Million USD | 30.63% |
2019 Q4 | 45.03 Million USD | 29.61% |
2019 Q3 | 34.74 Million USD | -1.89% |
2019 Q2 | 35.41 Million USD | 5.19% |
2019 Q1 | 33.66 Million USD | 0.0% |
2018 FY | 113.95 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Doximity, Inc. | 475.42 Million USD | 45.512% |
Evolent Health, Inc. | 1.96 Billion USD | 86.81% |
MultiPlan Corporation | 961.52 Million USD | 73.059% |
Phreesia, Inc. | 356.29 Million USD | 27.295% |
Teladoc Health, Inc. | 2.6 Billion USD | 90.046% |
Veeva Systems Inc. | 2.36 Billion USD | 89.04% |